DNA-dependent activator of interferon regulatory factor (DAI) acts as a cytosolic B-form DNA sensor that induces type I interferons. However, DAI is not required for DNA sensing in certain cell types due to redundancy of the DNA sensing system. Here, we investigated the effect of DAI on herpes simplex virus 1 (HSV-1) infection in HepG2 hepatocellular carcinoma cells. DAI transcription was induced after gamma interferon (IFN-␥) treatment or HSV-1 infection. HSV-1 replication was enhanced by DAI knockdown, and ectopic DAI expression repressed viral replication in a manner requiring the Z␤ and D3 domains, but not the Z␣ domain. This activity of DAI was more prominent at low multiplicity of infection (MOI) and correlated with the reduced expression of viral immediate-early genes. Consistently, DAI repressed the activation of ICP0 promoter in reporter gene assays.
D NA-dependent activator of interferon (IFN) regulatory factor (DAI), which is also referred to as Z-DNA binding protein 1 (ZBP1) or DLM-1, was initially identified as a highly upregulated protein in mouse tumor stromal cells and in macrophages treated by gamma IFN (IFN-␥) or lipopolysaccharide (1) . Structural analyses have revealed that DAI/ZBP1/DLM-1 (referred to as DAI hereafter) contains the amino-terminal Z-form DNA-binding domains, Z␣ and Z␤, which are homologous to those of adenosine deaminase that acts on RNA (ADAR1), an RNA editing enzyme (2) (3) (4) (5) . Since Z-DNA is located near the transcription start sites of certain genes in the genome, a role of DAI in transcriptional regulation has been suggested (6, 7) . Induction of DAI was also observed in mouse hepatocytes infected with hepatitis B virus (HBV) (8) and in mouse embryonic fibroblasts (MEFs) stimulated by B-form DNA (9) .
Recently, DAI was shown to act as a cytosolic B-form DNA sensor that initiates IFN responses via activation of the nuclear factor-B (NF-B) and interferon regulatory transcription factor 3 (IRF3) pathways in mice (10) . In addition to the Z-DNA-binding domains, a region termed the D3 domain was demonstrated to primarily contribute to the recognition of B-DNA in vitro (10) . However, all of the Z␣, Z␤, and D3 domains were required for efficient B-DNA binding in vivo and DAI was suggested to undergo DNA-mediated multimerization to evoke activation of IFN responses (11) . The carboxyl-terminal region of DAI was responsible for recruitment of both IRF3 and TANK-binding kinase 1 (TBK1), an IB kinase that activates IRF3 (10) . The mechanism by which DAI activates the NF-B pathway was shown to involve recruitment of receptor-interacting protein kinase 1 (RIP1) and RIP3 through a RIP homotypic interaction motif (RHIM)-dependent interaction with DAI (12, 13) . Recently, the binding of DAI with RIP3 was shown to mediate virus-induced programmed necrosis (14) .
The requirement of DAI in induction of IFN response by cy-tosolic stimulation of B-DNA is dependent on cell type. DAI played a role in the DNA-mediated IFN production in mouse fibroblast L929 (10, 12, 15) and mouse SVEC4-10 endothelial cells (12) , whereas it was not required for MEFs (11, 16) and mouse bone marrow dendritic cells generated by granulocyte macrophage colony-stimulating factor or Fms-like tyrosine kinase 3 (16) . In L929 cells, mouse microglial cells, and astrocytes, IFN production upon herpes simplex virus 1 (HSV-1) infection also required DAI expression (17) . Among human cells, A549 lung carcinoma cells did not require DAI for the DNA-mediated IFN production, whereas HEK293 embryonic kidney cells only partially did so (15) . Human fibroblast cells required DAI for the IFN production after human cytomegalovirus infection (18, 19) . These reports suggest that the cytosolic DNA sensing system for the induction of IFN responses may be redundant, depending on different receptors in different cell types. Although DAI has been shown to reduce the growth of HSV-1 in certain cell types, the role of DAI in cell types that do not necessarily require DAI for DNA sensing has not been demonstrated. In the present study, we show that DAI can inhibit HSV-1 replication through mechanisms independent of DNA sensing. Our data demonstrate that DAI acts as a restriction factor that sup-presses viral gene activation especially at a low multiplicity of infection (MOI). Furthermore, we demonstrate that DAI interacts with ICP0 and that this interaction may also be involved in the anti-HSV-1 activity of DAI.
MATERIALS AND METHODS
Cell culture and virus. HepG2, MEF, Vero, BHK, U2OS, and 293T cells were grown in Dulbecco modified Eagle medium with 10% fetal calf serum, penicillin (100 U/ml), and streptomycin (100 g/ml) in a 5% CO 2 humidified incubator at 37°C. To induce DAI expression HepG2 cells were treated with IFN-␥ (100 ng/ml; Sigma-Aldrich) for 20 h. HSV-1 (strain KOS/tk12) contained a lacZ reporter gene under the control of the ICP4 promoter inserted into the thymidine kinase (TK) gene (20) . The mutant virus dlX3.1 has an ICP0 deletion in the KOS background (21) . The wild-type virus (KOS/tk12) was grown and titrated in Vero cells by plaque assays. The dlX3.1virus was grown in BHK cells and titrated in U2OS cells, in which ICP0 is not required for efficient replication of HSV-1 (22) .
Plasmids. Plasmids expressing 5= hemagglutinin (HA)-tagged human DAI (1 to 429 amino acids), its amino-terminal fragment (Z␣ϩZ␤), or an amino-terminal truncated version (⌬1-80) were previously described (23) . The ⌬Exon2 (⌬E2) mutant with a deletion between amino acids 12 and 86 and the ⌬Exon4/5 (⌬E4/5) mutant with a deletion between amino acids 110 and 223 were generated by PCR in the same pSG5 (24) background. Retroviral vectors, MIN-DAI and MIN-⌬E4/5, were constructed by inserting the corresponding DAI cDNAs into pMIN (25) . The cDNA for human RIP1 was provided by Jaehwan Song (Yonsei University, Seoul, Republic of Korea). Plasmid for 5=-HA-tagged RIP1 was produced in pSG5 background using Gateway technology (Invitrogen). Plasmid encoding ⌬RHIM mutant RIP1 was generated by PCR in the same background. Plasmid expressing ICP0 was previously described (26) and an ICP0-luciferase reporter gene plasmid was provided by Gary S. Hayward (Johns Hopkins University School of Medicine).
Transfection. HepG2 and MEF cells were transfected with plasmid DNAs using the Metafectene reagents (Biontex). For cytosolic B-DNA stimulation, HepG2 cells were transfected with poly(dA-dT)-poly(dA-dT) (Sigma-Aldrich) using Lipofectamine 2000 reagents (Invitrogen). 293T cells were transfected via the N,N-bis-(2-hydroxyethyl)-2-aminoethanesulfonic acid-buffered saline (BBS) version of the calcium phosphate method, as described previously (26) . Lentiviral vectors. Lentiviral vector pLKO.1-TRC control expressing a non-hairpin control RNA (shC) was purchased from Addgene. Lentiviral vectors (on a pLKO.1 background) expressing short hairpin RNAs (shRNAs) against DAI (shDAI-A to E), which correspond to TRCN0000123049 to TRCN0000123053, respectively, were purchased from Open Biosystems. To produce lentiviruses, 293T cells were transfected with lentiviral vectors together with plasmids pCMV-DR8.91 expressing the Gag-Pol, Tat, and Rev proteins of human immunodeficiency virus and pMD-G expressing the envelope G protein of vesicular stomatitis virus (VSV), provided by Kyeong Ho Lee (Yonsei University Wonju Campus, Wonju, Republic of Korea). At 2 days after transfection, the culture media containing the lentiviruses were harvested and stored at Ϫ70°C. HepG2 cells were transduced with lentivirus supernatants in the presence of Polybrene (7.5 g/ml), and then were selected with puromycin (1 g/ml). The selected cells were maintained in a medium containing puromycin (0.5 g/ml). Two shRNAs, shDAI-B and shDAI-E, effectively suppressed DAI expression and were referred to as shDAI-1 and shDAI-2.
Retroviral vectors. Recombinant retroviruses were prepared by cotransfecting 293T cells with retroviral vectors MIN or MIN-DAI (wildtype or mutant) together with packaging plasmids pHIT60 (Gag-Pol) and pMD-G (VSV-G) (27) using Metafectene reagents (Biotex). Viral supernatants were harvested at 48 h after transfection. HepG2 cells were transduced by retroviruses in the presence of Polybrene (7.5 g/ml). Cells were selected with G418 (0.5 mg/ml; Calbiochem).
Plaque assays. The serially diluted virus samples were used to inoculate Vero or U2OS cells in a six-well plate (10 6 per well). After 1 h of incubation, the medium was removed, and 2 ml of methylcellulose overlay was added to each well. After incubation for 3 days, the methylcellulose was removed, and the cell monolayer was stained with 1% crystal violet in 50% ethanol for 20 min. The cells were washed with running tap water and dried. The numbers of plaque produced were counted.
Antibodies. Anti-DAI polyclonal antibody (PAb) (23) was previously described. Anti-HA rat monoclonal antibody (MAb) 3F10 conjugated with peroxidase or labeled with fluorescein isothiocyanate (FITC) and anti-Myc mouse MAb was purchased from Roche. Mouse MAbs for UL42 and IFI16 and rabbit PAb for IRF3 were purchased from Santa Cruz Biotechnology. Mouse MAb for ICP0 was purchased from Virusys. The rabbit PAbs against ICP0 and PML were a gift from Gary S. Hayward (Johns Hopkins University School of Medicine). Rabbit MAb for phosphorylated IRF3 (S396) was obtained from Cell Signaling Technology. Mouse MAbs for IB␣ and ␤-actin were purchased from Young In Frontier (Seoul, Republic of Korea) and Sigma-Aldrich, respectively.
Indirect immunofluorescence assay (IFA). Cells were fixed for 5 min in cold methanol and rehydrated in cold phosphate-buffered saline (PBS). The cells were incubated with appropriate primary antibody in PBS at 37°C for 1 h and then with secondary antibody in PBS at 37°C for 45 min. To stain nuclei, mounting solution containing DAPI (4=,6=-diamidino-2phenylindole; Vector Laboratories) or Hoechst strain (Invitrogen) and antifade reagent (Molecular Probes) were used. Slides were examined and photographed with a Carl Zeiss Axiophot microscope or with a Carl Zeiss Axioplan 2 confocal microscope system with LSM510 software.
Immunoblot analysis. Cells were collected and lysed with an ice-cold RIPA buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate [SDS]) supplemented with protease inhibitor cocktail (Santa Cruz). Clarified cell extracts were separated by SDS-polyacrylamide gel electrophoresis (PAGE), and the resolved proteins were transferred onto nitrocellulose membranes (Schleicher & Schuell, Dassel, Germany). All subsequence procedures were performed as previously described (23) .
␤-Galactosidase reporter assay. Cells were collected and lysed by three freeze-thaw steps in 100 l of 0.25 M Tris-HCl (pH 7.9) plus 1 mM dithiothreitol. Cells extracts were clarified in a microcentrifuge. Each reaction mix was prepared in 96-well dishes including 20 l of extracts plus 100 l of Z-buffer (0.06 M Na 2 HPO 4 , 0.04 M NaH 2 PO 4 , 0.01 M KCl, 0.001 M MgSO 4 , 0.05 M ␤-mercaptoethanol) plus 20 l of ONPG (onitrophenyl-␤-D-galactopyranoside [Sigma-Aldrich]; 4 mg/ml in sterile water). Reactions were incubated at 37°C until the yellow color was developed. Reaction was stopped by adding 50 l of 1 M Na 2 CO 3 . The ␤-galactosidase absorbance of each reaction was read at 420 nm.
Cell viability assay. Cells were seeded in 96-well flat-bottom plates and infected with virus at an MOI of 3. At 24 h after infection, 10 l of WST-1 solution (EZ-Cytox; Daeil Lab Service) was added to the 96-well cell culture, and the plates were incubated at 37°C in 5% CO 2 for 2 h. The colorimetric determination of WST-1 was measured at 460 nm with a xMARK microplate spectrophotometer plate reader (Bio-Rad).
Reverse transcription-PCR (RT-PCR) and quantitative real-time PCR. Total RNA was isolated from 2 ϫ 10 5 cells using TRIzol reagent (Invitrogen). cDNAs were synthesized using the random hexamer primers in the SuperScript III system (Invitrogen). Quantitative real-time PCR was performed using SYBR Green PCR Core Reagents (Applied Biosystems) and ABI Prism SDS software. The following primers were used: human DAI, forward (5=-CAACAACGGGAGGAAGACAT-3=) and reverse (5=-TCATCTCATTGCTGTGTCCC-3=); ICP4, forward (5=-CTCA TCGTGGTCAACACCGT-3=) and reverse (5=-CTTCCCAGTCCACAAC GTCC-3=); ICP27, forward (5=-AGCCTCTATCGCACTTTTGC-3=) and reverse (5=-ACACGACTCGAACACTCCTG-3=); IFN-␤, forward (5=-GC TCTCCTGTTGTGCTTCTCCAC-3=) and reverse (5=-CAATAGTCTCA TTCCAGCCAGTGC-3=); and ␤-actin, forward (5=-AGCGGGAAATCG TGCGTG-3=) and reverse (5=-CAGGGTACATGGTGGTGCC-3=).
Luciferase reporter assay. Cells were collected and lysed by three freeze-thaw steps in 200 l of 0.25 M Tris-HCl (pH 7.9) plus 1 mM dithiothreitol. Cell extracts were clarified in a microcentrifuge, and 30-l portions of the of extracts were incubated with 350 l of reaction buffer A (25 mM glycyl-glycine [pH 7.8], 15 mM ATP, 4 mM EGTA) and then mixed with 100 l of 0.25 mM luciferin (Sigma-Aldrich) in reaction buffer A. A TD-20/20 luminometer (Turner Designs) was used for a 10-s assay of the photons produced (measured in relative light units).
CoIP assays. Cell lysates were prepared by sonication in 1 ml of coimmunoprecipitation (CoIP) buffer (50 mM Tris-Cl [pH 7.4], 50 mM NaF, 5 mM sodium phosphate, and 0.1% Triton X-100 containing protease inhibitors; Sigma-Aldrich) with a Vibra cell microtip probe (Sonics and Materials) for 10 s (pulse on, l s; pulse off, 3 s). Cell lysates were incubated for 16 h with the appropriate antibody at 4°C. A total of 30 l of a 50% slurry of protein G-Sepharose (Amersham) was added and then absorbed for 1 h at 4°C. The mixture was pelleted and washed several times with CoIP buffer. The beads were resuspended and boiled for 5 min in loading buffer. Each sample was analyzed by SDS-PAGE and immunoblotting with the appropriate antibody.
Statistical analysis. Statistical significance between samples was determined using the Student t test. P values of Ͻ0.05 (*), Ͻ0.01 (**), and Ͻ0.001 (***) are indicated in the figures.
RESULTS

Depletion of DAI enhances HSV-1 replication. DAI has been
shown to be induced in hepatic cells by interferon treatment and HBV infection (8, 23) . In RT-PCR analysis, we found that DAI transcription was induced in HepG2 cells after IFN-␥ treatment or HSV-1 infection (Fig. 1A) . Human hepatic cells have been used successfully to study intrinsic restriction factors such as PML, Sp100, ATRX, and Daxx in HSV-1 infection (28, 29) . To investigate the possible role of DAI in HSV-1 replication, DAI-depleted HepG2 cells were produced by transduction with lentiviral vectors expressing shRNAs for DAI. Transcription of endogenous DAI was suppressed by two different shRNAs (shDAI-1 and shDAI-2) but not by control RNA (shC), and shDAI-1 and shDAI-2 efficiently suppressed DAI transcription in HSV-1-infected cells (Fig.  1B ). The expression of DAI protein from transfected plasmid DNA was also efficiently suppressed in these DAI shRNA-expressing HepG2 cells (data not shown). We infected control and DAIknockdown cells with recombinant HSV-1 (KOS/tk12 strain) at an MOI of 1 or 3 for 24 h and measured the amounts of progeny virions produced in the culture supernatants by plaque assays using Vero cells. Virus titers were higher in shDAI-1 and shDAI-2 cells by about 10-and 15-fold, respectively, than those in normal and control (shC) cells at an MOI of 1 (Fig. 1C) . Similarly, a 4-to 6-fold increase of virion production was observed in DAI-knockdown cells at an MOI of 3 ( Fig. 1D) . Notably, the repressive effect of DAI was more prominent at lower MOI. The plaque sizes were comparable between control and DAI-knockdown cells (data not shown). When the accumulation of viral ICP0 (immediate-early) and UL42 (early) proteins was compared between control and DAI-knockdown cells at 24 h after infection, the levels of viral ICP0 and UL42 proteins were significantly higher in DAI-knockdown cells at MOI of 1, whereas they were slightly increased at MOI of 3 ( Fig. 1E and F) . The increased ICP0 expression by DAI- knockdown was observed at 3 h after infection ( Fig. 1G ). Together, these results demonstrate that DAI knockdown in HepG2 cells facilitates HSV-1 replication by promoting viral gene expression and that this effect is more profound at a lower MOI.
DAI expression represses HSV-1 growth and ICP0 promoter activation. We next investigated the effect of ectopic expression of DAI on HSV-1 replication. Retroviral vectors expressing wildtype or mutant DAI (⌬E2, Z␣ domain deleted; ⌬E4/5, Z␤ and D3 domains deleted; and Z␣ϩZ␤, containing only Z␣ and Z␤ domains) were constructed ( Fig. 2A ). HepG2 cells expressing these DAI proteins were produced by retroviral transduction. These cells were infected with HSV-1 for 24 h and the production of ␤-galactosidase, which is expressed under the control of the ICP4 promoter in the viral genome, in infected cells was measured. Expression of wild-type and ⌬E2 mutant DAI efficiently repressed the ␤-galactosidase production, whereas ⌬E4/5 and Z␣ϩZ␤ mutants almost completely lost the repressive activity ( Fig. 2B ). When the levels of progeny virion production were compared between wild-type and mutant DAI-expressing cells, wild-type DAI significant reduced virus titer, whereas ⌬E4/5 mutant had a minimal effect (Fig. 2C) . The repressive effect of wild-type DAI on viral replication correlated with the reduced expression of ICP0 and UL42 (Fig. 2C ). Both wild-type and ⌬E4/5 mutant DAI expressed by retroviral vectors were mainly distributed in the cytoplasm as a mixture of diffuse and punctate forms, with some also being localized in the nucleus as foci (Fig. 2D ). When HepG2 cells [Wt] or mutant)-expressing retrovirus were mock infected or infected with HSV-1 at an MOI of 3. At 24 h, the cell lysates were prepared and assayed for ␤-galactosidase production by ONPG assays. The expression levels of wild-type and mutant DAI were determined by immunoblotting with anti-DAI antibody. (C and D) Control (MIN) or DAI-expressing (MIN-Wt or MIN-⌬E4/5 mutant) cells were mock infected or infected with HSV-1 at an MOI of 3 for 24 h. (C) Virus titers in culture supernatants were measured by plaque assays, and the levels of viral ICP0 and UL42 proteins and DAI proteins in cell lysates were determined by immunoblotting. (D) Cells were fixed with the methanol procedure and stained with anti-DAI antibody and fluorescence isothiocyanate (FITC)-labeled donkey anti-rabbit IgG. A mounting solution containing DAPI was used to stain cell nuclei. (E) Normal HepG2 cells were transfected with empty plasmid or increasing amounts of plasmid expressing HA-tagged wild-type or ⌬E4/5 mutant DAI. At 24 h, these cells were mock infected or infected with HSV-1 at an MOI of 3. After further incubation for 24 h, the ␤-galactosidase levels were measured. The levels of DAI and ␤-actin proteins were determined by immunoblotting. (F) Control or DAI-expressing cells were mock infected or infected with HSV-1at an MOI of 3 for 24 h. The levels of ICP0 and ICP27 mRNA were measured by RT-PCR. The levels of ␤-actin are shown as loading controls.
was transiently transfected with wild-type and ⌬E4/5 mutant DAI and then infected with HSV-1 for 24 h, wild-type DAI inhibited the production of ␤-galactosidase in a dose-dependent manner, whereas ⌬E4/5 mutant did not ( Fig. 2E ). The levels of ICP0 and ICP27 mRNAs were reduced by the expression of wild-type DAI but not ⌬E4/5 mutant, suggesting that the anti-HSV-1 effect of DAI expression includes transcriptional control (Fig. 2F ). Collectively, these results demonstrate that DAI inhibits HSV-1 growth and that the anti-HSV-1 activity requires the central region encompassing Z␤ and D3 domains but not the amino-terminal region containing Z␣ domain. To investigate whether DAI expression affects HSV-1 IE gene expression, transient reporter gene assays were performed in HepG2 cells using the ICP0-luciferase reporter gene plasmid. When control and DAI-knockdown cells were transfected with the reporter gene plasmid, the ICP0 promoter activity was higher in DAI-knockdown cells than control cells (Fig. 3A) . When cells were cotransfected with the reporter gene plasmid and DAI-expressing plasmid, DAI repressed the ICP0 promoter in a dosedependent manner (Fig. 3B) . Consistent with the data obtained with virus infection (in Fig. 2) , DAI mutants without the Z␣ domain (⌬1-80 and ⌬E2) still showed wild-type activity, but ⌬E4/5 mutant lost this repressive activity (Fig. 3C) . When cells expressing wild-type DAI or ⌬E4/5 mutant were transfected with the reporter gene plasmid, the ICP0 promoter was repressed by wildtype DAI, but not by ⌬E4/5 mutant (Fig. 3D) . In a control experiment, DAI repressed the human T cell leukemia virus (HTLV) long terminal repeat (LTR) but not the cyclin E promoter (Fig. 3E ). This result suggests that DAI may be a general repressor, although the activity is found in a promoter-dependent manner. Therefore, these results of reporter gene analysis demonstrate that the anti-HSV-1 activity of DAI at least in part involves inefficient expression of viral ICP0 gene.
DAI is not essential for IFN-␤ transcription through cytosolic B-DNA sensing in HepG2 cells. We investigated whether DAI plays an essential role in the type I IFN pathway in HepG2 cells after treatment of immunostimulatory B-DNA. First, we tested or HepG2 (B) cells were cotransfected with plasmids expressing myc-DAI and HA-RIP1(Wt) or HA-RIP1(⌬RHIM). At 48 h, total cell lysates were immunoprecipitated with anti-myc antibody, followed by immunoblotting with anti-HA antibody. The total protein levels of DAI and RIP1 proteins in the cell extracts were also determined by immunoblotting. (C) HepG2 cells were single transfected with plasmids expressing HA-RIP1, HA-RIP1(⌬RHIM), or flag-DAI (a to c) or cotransfected with plasmids for flag-DAI and HA-RIP1(Wt or ⌬RHIM) (d to i). At 24 h, cells were fixed with cold methanol and subjected to IFA. For single labeling, cells were stained with FITC-labeled anti-HA antibody (a and b) or anti-flag M2 antibody and rhodamine/redX-coupled donkey anti-mouse IgG (c). For double-labeling (d to f and g to i), cells were incubated with two primary antibodies together. (D to F) 293T (D) or HepG2 (E) cells were cotransfected with 0.1 g of NF-B-luciferase reporter plasmid, 0.5 g of SV2-␤-galactosidase reporter plasmid, and plasmids for flag-DAI and HA-RIP1(Wt or ⌬RHIM) as indicated. (F) HepG2 cells were transfected as described above and were untreated or treated with 3 g of poly(dA-dT) for 12 h prior to cell harvest. Total cell lysates were prepared at 24 h after transfection and assayed for luciferase activity. The luciferase activity was normalized with the ␤-galactosidase activity. Shown are mean values with the standard errors of luciferase activity of three independent assays. The expression levels of DAI and RIP1 proteins were determined by immunoblotting with anti-flag and anti-HA antibodies. The level of ␤-actin is also shown as a loading control. induction of IFN-␤ mRNA synthesis in HepG2 cells after cytosolic B-DNA stimulation. The results of quantitative real-time RT-PCR showed that the IFN-␤ mRNA level was increased by poly(dA-dT) stimulation in a dose-dependent manner; the maximum increase in this experiment was observed with stimulation of cells with 3 g of poly(dA-dT) for 12 h (Fig. 4A ). We found that the B-DNAmediated induction of IFN-␤ transcription in this condition was similar between control and DAI-knockdown cells (Fig. 4B ). Since IFN-␤ transcription is activated by IRF3 and NF-B, we further examined the effect of DAI-knockdown on activation of IRF3 and NF-B. Consistent with the data for IFN-␤ mRNA levels, both phosphorylation of IRF3 at serine 396 and degradation of IB␣ after poly(dA-dT) stimulation were comparable between control and DAI-knockdown HepG2 cells (Fig. 4C) . Taken together, these results suggest that DAI is not essential for the IFN-␤ production through cytosolic B-DNA sensing in HepG2 cells.
To further investigate the effect of DAI expression on NF-B activation in HepG2 cells, we examined the effect of DAI-RIP1 interaction on the plasmid DNA transfection-dependent DAImediated activation of NF-B (12, 13) . As observed in these previous reports, human DAI interacted with wild-type RIP1 but not with ⌬RHIM mutant in cotransfected 293T and HepG2 cells ( Fig.  5A and B) . Consistently, RIP1was relocalized to cytoplasmic DAI foci in cotransfected cells in a RHIM-dependent manner (Fig. 5C ). In reporter assays, a synergistic effect of DAI and RIP1 expression on NF-B activation was observed in 293T cells (Fig. 5D ), and this was also consistent with previous reports (12, 13) . However, cotransfection of DAI and RIP1 did not enhance NF-B activation in HepG2 cells (Fig. 5E ). Furthermore, the B-DNA-mediated activation of NF-B was normally observed in HepG2 cells, but this was not augmented by the overexpression of DAI and RIP1 (Fig. 5F) . These results indicated that DAI interacted with RIP1, but their overexpression did not enhance the NF-B activation by B-DNA treatment in HepG2 cells. Collectively, our analysis demonstrates that DAI is not essential for the IFN-␤ production through IRF3 and NF-B activation upon stimulation by cytosolic B-DNAs in HepG2 cells.
Interaction of DAI with ICP0. We examined the localization pattern of DAI in HSV-1-infected HepG2. In normal HepG2 cells, the endogenous DAI proteins were detected at very low level throughout the cells (Fig. 6Aa to c) , although a few cytoplasmic DAI foci were detected in only a minority of cells (data not shown). After HSV-1 infection, the number of cells showing the DAI signals in the cytoplasm and often in the nucleus was increased at 3 h ( Fig. 6Ad to i) . ICP0 localizes to the nucleus at the early phase of infection and then is also distributed in the cytoplasm as diffuse and punctate forms at the late phase (30) (31) (32) (33) . We found that some DAI induced in HSV-1-infected cells colocalized with ICP0 in the nuclear and cytoplasmic foci ( Fig. 6Ad to j, note the closed barbed arrowheads for nuclear colocalization and open arrowheads for cytoplasmic colocalization in panel j).
We previously demonstrated that transfected DAI was localized largely in the cytoplasm, but also in the nucleus in several cell types, including HepG2 (23) . When HA-DAI-transfected HepG2 cells were infected with HSV-1 for 8 h, we found that HA-DAI effectively colocalized with ICP0 in the nucleus and the cytoplasm (Fig. 6B) . Notably, the cytoplasmic ICP0 foci was less efficiently found in HA-DAI-expressing cells, suggesting that overexpression of DAI by transfection may delay the relocalization of ICP0 into the cytoplasm (Fig. 6B a to c) . Collectively, the results of the IFA suggest a specific association of DAI with ICP0 during HSV-1 infection.
Therefore, we further investigated the interaction of DAI with ICP0 using CoIP assays. When 293T cells were cotransfected with cells were mock infected (a to c) or infected with HSV-1 for 3 h (d to j) at an MOI of 1. Cells were fixed with methanol and then subjected to double-label IFA with anti-DAI and anti-ICP0 antibodies. Hoechst stain was used to stain cell nuclei. For infected cells, the representative images taken from two different microscopic fields (d to f and g to i) are shown. Two single-labeled IFA images and a merged image (green for DAI, red for ICP0, and blue for DNA) for each sample are shown. Panel j is an enlarged image of a dashed box in panel i. The closed barbed arrowheads indicate the colocalization signals of DAI and ICP0 in the nucleus in two selected cells, whereas the open arrowheads indicate their colocalization signals in the cytoplasm. The images were obtained by confocal microscopy. (B) HepG2 cells were transfected with plasmid expressing HA-DAI for 24 h and then infected with HSV-1 for 8 h. The cells were fixed with methanol and then subjected to double-label IFA with anti-HA and anti-ICP0 antibodies. Hoechst stain was used to stain cell nuclei. The representative images taken from three different microscopic fields (a to c, d to f, and g to i) are shown. Two single-labeled IFA images and a merged image (green for HA-DAI, red for ICP0, and blue for DNA) for each sample are shown. The images were obtained by confocal microscopy. myc-DAI and ICP0, immunoprecipitation of myc-DAI coprecipitated ICP0 and, in reciprocal assays, immunoprecipitation of ICP0 coprecipitated myc-DAI (Fig. 7A ). DAI ⌬E4/5 mutant did not interact with ICP0, as well as wild-type DAI, indicating that the central region encompassing Z␤ and D3 domains is required for efficient ICP0 binding (Fig. 7B ). We also examined the DAI-ICP0 interaction in HSV-1-infected cells. Since the DAI antibody used could not detect endogenous low-level DAI in immunoblot analysis, we could not detect the association of endogenous DAI with ICP0 in HSV-1-infected HepG2 cells. However, when HepG2 cells transiently transfected with HA-DAI were infected with HSV-1, ICP0 was coprecipitated with DAI ( Fig. 7C) . The association of DAI with ICP0 during virus infection was further assessed using wild-type or ⌬E4/5 mutant DAI-expressing HepG2 cells. When these control (MIN) and DAI-expressing (MIN-DAI or MIN-DAI-⌬E4/5) cells were infected with HSV-1, immunoprecipitation of wild-type DAI, but not ⌬E4/5 mutant, coprecipitated ICP0 (Fig. 7D) . These results confirm that DAI indeed interacts with ICP0.
ICP0 is involved in DAI-mediated repression of HSV-1 growth. We demonstrated that DAI expression more significantly inhibits ICP0 expression at lower MOI (Fig. 1) . In addition to the effect of DAI on viral IE gene expression, the interaction of DAI with ICP0 may also affect viral growth. To test it, we compared the effects of DAI knockdown and overexpression on the growth of wild-type and ICP0-deleted mutant viruses. The dlX3.1 virus contained a 3.1-kb deletion in both copies of the ICP0 gene in the HSV-1 genome and, therefore, completely loses all ICP0 functions (21) . We first infected normal and DAI-knockdown HepG2 cells at an MOI of 3 and then compared the growth of wild-type and dlX3.1 mutant viruses by measuring the level of progeny virion production. In normal and control (shC) HepG2 cells, the dlX3.1 virus growth was reduced by Ͼ10-fold compared to the wild-type virus growth (Fig. 8A) . Importantly, we found that, unlike wild-type virus, the growth of dlX3.1 virus was not affected by DAI knockdown (Fig. 8A) . The growth of wild-type and dlX3.1 mutant viruses was also compared between control (MIN) and DAI-expressing [MIN-DAI and MIN-DAI(⌬E4/5)] cells. The results showed that, unlike wild-type virus, the growth of dlX3.1 virus was not repressed by wild-type DAI expression ( Fig. 8B ).
Since the high-level expression of DAI mediates virus-induced programmed necrosis in certain cell types, in which RIP3 was also expressed at high level (14) , we investigated whether the DAImediated inhibition of HSV-1 growth is related to increased cell death. However, the levels of cell viability after infection with HSV-1 were similar among control and DAI-expressing cells, indicating that the anti-HSV-1 activity of DAI in HepG2 cells may be independent of virus-induced necrosis (Fig. 8C ).
DAI is not required for the DNA-mediated production of IFN-␤ in MEFs (11, 16) . Therefore, we also tested whether the expression of DAI inhibits HSV-1 replication in MEFs in an ICP0dependent manner. MEFs expressing wild-type or ⌬E4/5 mutant DAI were produced by retroviral vectors and infected with wildtype or ICP0 mutant virus. Like in HepG2 cells, the expression of wild-type DAI, but not ⌬E4/5 mutant, repressed HSV-1 replication in MEFs, and that this repressive effect of DAI was not observed in dlX3.1 virus infection (Fig. 8D) . Collectively, the results with the ICP0-deleted mutant virus demonstrated that the repression of HSV-1 growth by DAI in HepG2 cells and MEFs requires the presence of ICP0 protein, suggesting that the DAI-ICP0 interaction may contribute to anti-HSV-1 activity of DAI.
We further investigated whether DAI expression affects the ICP0's Ub E3 ligase activity. It was recently shown that another DNA sensor IFI16 is degraded by ICP0 during HSV-1 infection in human fibroblasts (34) . We also observed that IFI16 was degraded in HepG2 cells after infection with wild-type HSV-1 but not with dlX3.1 mutant virus (Fig. 9A) . When compared between control and DAI-knockdown cells, the loss of IFI16 and PML (another substrate of ICP0) during virus infection was increased by DAI knockdown (Fig. 9B) . These results indicate that DAI expression downregulates the ICP0's Ub E3 ligase activity, suggesting that the DAI-ICP0 interaction may affect the ICP0 function.
DISCUSSION
The present study demonstrates that DAI is not required for DNA sensing-mediated IFN-␤ production in HepG2 cells. Cytosolic stimulation of normal cells with B-form DNA induced IFN-␤ transcription, but this was not affected by DAI knockdown. In other cell types where DAI act as a DNA sensor, DNA sensing through DAI activates both IRF3 and NF-B pathways (10, 12, 13) . However, in HepG2 cells, DAI knockdown did not affect B-DNA-mediated IRF3 activation, and the overexpression of DAI and RIP1 did not enhance NF-B activation even after B-DNA treatment. These observations support the idea that the cytoplasmic DNA sensing system is redundant. In agreement with this notion, several other cytosolic DNA-sensing proteins, including absent in melanoma 2 (AIM2), RNA polymerase III, DHX9 and DHX36, and IFN-inducible IFI16 protein, have been discovered (35, 36) . Therefore, it is likely that the involvement of a specific DNA sensor depends on cell types. Whether these receptors coordinately operate in a specific cell type is not clear.
Despite no apparent effect of DAI on the DNA-mediated IFN production in HepG2 cells, our data demonstrate that DAI expression inhibits HSV-1 growth. The anti-HSV-1 activity of DAI independent of DNA sensing was also evidenced by the finding that this DAI activity did not require the amino-terminal Z␣ domain, which is necessary for efficient B-DNA binding in vivo (11) . Our data demonstrate that one apparent mechanism by which DAI inhibits HSV-1 growth is through suppression of viral IE gene expression. DAI knockdown increased the accumulation of ICP0 (and ICP4 [data not shown]) in virus-infected cells, whereas DAI overexpression reduced it. Furthermore, our reporter gene analysis showed that DAI inhibits the activation of ICP0 promoter. We consistently observed that the effect of DAI on viral gene expression is prominent at lower MOIs. This property resembles those of PML-NB-associated intrinsic restriction factors such as PML and Sp100. DAI was also found to be associated with PML-NBs (23) and ICP0 in the nucleus (the present study). Therefore, it is likely that DAI acts as a restriction factor that suppresses incoming viral genomes.
Our study did not address whether DAI-colocalizing ICP0 in the nucleus is associated with PML or not. However, we observed that transfected HA-DAI(⌬E4/5), which did not interact with ICP0, was not associated with PML (data not shown). Since a recent study reported that ICP0 interacts with PML-I, the most abundant PML isoform (37) , it is possible that PML is involved in the association of DAI with ICP0. We also consistently observed that transfected DAI more efficiently localized in the nucleus than did endogenous DAI. Since a large number of DAI isoforms are expressed via alternative splicing (4) and DAI self-interacts with each other (11) , it is possible that the DAI isoforms are differently distributed within the cell or the interaction between DAI isoforms may regulate their intracellular localization.
A role of DAI in virus-induced necrosis has been demonstrated in mouse cytomegalovirus infection (14, 38) . Therefore, it is conceivable that the DAI-mediated cell death also contributes to the anti-HSV-1 activity of DAI. However, this scenario is unlikely in HepG2 cells, since control and DAI-expressing cells exhibited similar cell viability after virus infection in our experimental conditions. Furthermore, it has been shown that the level of necrotic response in several cell types correlates with RIP3 level (39) and that the virus-induced necrosis requires high-level expression of both RIP3 and DAI (14) . However, we observed that RIP3 in HepG2 cells was expressed at a low level, as in 293T (data not shown), where necrotic response was not observed (39) .
The results in the present study further demonstrate that DAI may inhibit HSV-1 growth by regulating ICP0 functions. This conclusion is supported by several observations. First, DAI interacted with ICP0. Second, DAI knockdown enhanced replication of wild-type virus but not the ICP0 deletion mutant. Third, DAI overexpression inhibited replication of wild-type virus but not ICP0 deletion mutant, and a mutant DAI defective in ICP0 binding lost its anti-HSV-1 activity. Moreover, it should be emphasized that the ICP0-dependent anti-HSV-1 activity of DAI was also observed in MEFs in which DAI is not required for DNAmediated IFN production. Therefore, even in cell types where DAI is not necessarily required for DNA sensing, DAI appears to inhibit HSV-1 growth via different mechanisms, suppressing viral genomes and targeting to ICP0. In this respect, it is also notable that IFI16 was recently shown to act as an intrinsic restriction factor that inhibits the transcriptional activation of viral replication genes (40) .
The ubiquitin E3 ligase function of ICP0 (41, 42) is thought to be involved in antagonizing cellular antiviral activities. The ICP0-mediated degradation of PML in the nucleus promotes viral growth by relieving the suppressive effect of PML on incoming viral genomes (43) . ICP0 has also been shown to downregulate the production of IFN and IFN-stimulated genes during virus infection (44, 45) . This repression by ICP0 at least in part involved the inhibition of IRF3 activity (33, 46, 47) . A recent study also demonstrated that ICP0 degrades IFI16, and this activity is involved in inhibition of IRF3 activation (34) . Our data here demonstrate that DAI expression inhibits the degradation of PML and IFI16 by ICP0. These results suggest that the association of DAI with ICP0 may regulate the E3 ligase activity of ICP0 that is crucial for HSV-1 replication. Further studies are required to address the exact roles of DAI-ICP0 interaction in the DAImediated inhibition of HSV-1 growth.
